First clinical trial initiated for Bundibugyo Ebola strain vaccine

A volunteer has received the first dose of an experimental vaccine targeting the Bundibugyo strain of the Ebola virus. This marks the commencement of initial clinical testing for a strain that previously lacked a dedicated prophylactic, though the efficacy and safety profile remain to be established through the trial process.